A 2-stage Phase 1 Study of Safety, Tolerability, PK, and PD of IW-1973 Tablet in Healthy Volunteers in an Open-label, Single-dose Stage, and a Randomized, Double Blind, Placebo-controlled, Multiple-ascending-dose Stage

Trial Profile

A 2-stage Phase 1 Study of Safety, Tolerability, PK, and PD of IW-1973 Tablet in Healthy Volunteers in an Open-label, Single-dose Stage, and a Randomized, Double Blind, Placebo-controlled, Multiple-ascending-dose Stage

Completed
Phase of Trial: Phase I

Latest Information Update: 17 Sep 2017

At a glance

  • Drugs IW 1973 (Primary)
  • Indications Cardiovascular disorders; Pulmonary arterial hypertension
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Ironwood Pharmaceuticals
  • Most Recent Events

    • 17 Sep 2017 Results presented at the Council on Hypertension Scientific Session 2017
    • 25 Aug 2016 Status changed from active, no longer recruiting to completed.
    • 31 May 2016 Planned End Date changed from 1 Sep 2016 to 1 Jun 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top